Syntimmune Shareholders Win Again Over AZ, time for $181M
13 Jun 2025 //
FIERCE BIOTECH
AstraZeneca`s Alexion Loses $130M To Syntimmune In Post-Merger Suit
09 Sep 2024 //
FIERCE PHARMA
GSK submits its first application for daprodustat in Japan
22 Aug 2019 //
ENDPTS
Keeping up deal frenzy, Alexion strikes an RNAi pact
25 Oct 2018 //
BIOPHARMA DIVE
Alexion doles out $22M upfront for two preclinical RNAi drugs from Dicerna
24 Oct 2018 //
ENDPTS
Alexion to Acquire Syntimmune
27 Sep 2018 //
BUSINESSWIRE